Marco Alings

机构：Amphia Ziekenhuis · ORCID：0000-0003-2090-4683

发表论文 169 篇 · 总被引 23879 次 · h-index 46

代表论文

• Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation (2024 · Journal of the American College of Cardiology · 被引 73)
• Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial (2025 · The Lancet Neurology · 被引 50)
• Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials (2024 · European Heart Journal · 被引 36)
• Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial (2025 · Circulation · 被引 26)
• Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial (2024 · Circulation · 被引 25)
• Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial (2024 · Circulation Arrhythmia and Electrophysiology · 被引 10)